Ohio Public Employees Retirement System (OPERS)’s Akebia Therapeutics AKBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-27,200
Closed -$99K 2306
2025
Q2
$99K Buy
+27,200
New +$74.7K ﹤0.01% 1774
2023
Q1
Sell
-149,945
Closed -$87K 1988
2022
Q4
$87K Sell
149,945
-34,034
-18% -$10.7K ﹤0.01% 1491
2022
Q3
$58K Buy
+183,979
New +$72.2K ﹤0.01% 1815
2019
Q2
Sell
-30,240
Closed -$248K 1940
2019
Q1
$248K Buy
+30,240
New +$208K ﹤0.01% 1490

Other funds holding AKBA

Ohio Public Employees Retirement System (OPERS)'s AKBA Position: Q3 2025 in Review

Ohio Public Employees Retirement System (OPERS) sold out of Akebia Therapeutics (AKBA) in Q3 2025, closing a stake of 27,200 shares — an estimated $99K sold.

Ohio Public Employees Retirement System (OPERS) first reported a position in AKBA in Q1 2019 and held it in 4 quarters. The position peaked at $248K in Q1 2019. 177 funds tracked by Wall St. Rank hold AKBA as of Q3 2025.

  • Ohio Public Employees Retirement System (OPERS) reported no remaining Akebia Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Ohio Public Employees Retirement System (OPERS) sold 27,200 Akebia Therapeutics shares in Q3 2025, an estimated $99K.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Akebia Therapeutics in Q1 2019 and held it in 4 quarters.
  • Ohio Public Employees Retirement System (OPERS)'s Akebia Therapeutics position peaked at $248K in Q1 2019.
  • 177 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q3 2025.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q3 2025, filed 14 Nov 2025.